SEC 13F Intelligence

Bullseye Asset Management LLC / IMMU

Bullseye Asset Management LLC’s Immunomedics Inc Position

Does Bullseye Asset Management LLC own Immunomedics Inc (IMMU)? Not currently — the last reported position was 85.3K shares worth $7M in Q3 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$7M
Q3 2020
Shares
85.3K
% of Portfolio
+3.30%
Quarters Held
4
position exited

Position History IMMU

Reported value by quarter
Q4 ’19: $1MQ4 ’19Q1 ’20: $874,000Q1 ’20Q2 ’20: $3MQ2 ’20Q3 ’20: $7MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202085.3K$7M+3.30%
Q2 202085.4K$3M+1.62%
Q1 202064.8K$874,000+1.04%
Q4 201965.4K$1M+1.34%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bullseye Asset Management LLC’s full portfolio or all institutional holders of IMMU.